Benoît Hennion

With a dual background of strategy consulting and international pharma operations, Benoît joined forces in 2024 with Wandrille Ract-Madoux to build up and lead Tamrisa, a specialized pharma company dedicated to tackling anti-microbial resistance through Innovation, Stewardship & Access.

Incorporated in France, Tamrisa both develops new promising antibiotics against top priority multi-drug resistant pathogens, and commercializes proven existing antibiotics with a view to reinforce their access for patients around the world. As part of its model, Tamrisa is also committed to create all the conditions required for the appropriate use of antibiotics in human healthcare, and thus contribute to limit resistance expansion to both existing and future molecules.